The Effect of LI4 Acupressure on Perineal Pain and Postpartum Comfort During Episiotomy Repair
Launched by USKUDAR UNIVERSITY · May 6, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effect of a specific acupressure technique on reducing pain and improving comfort for women during the repair of an episiotomy, which is a cut made during childbirth. The researchers want to see if applying pressure to a point on the right hand can help alleviate perineal pain and enhance postpartum comfort. The study will take place at a hospital in Istanbul from May 2024 to October 2025, involving 90 pregnant women who are in labor and agree to participate.
To be eligible for the study, participants must be Turkish-speaking women who are 37 to 42 weeks pregnant with a single baby and are experiencing vaginal labor. They should also require a mediolateral episiotomy for delivery. During the study, women in the experimental group will receive acupressure on the LI4 point, while those in the placebo group will have a different point pressed. There will also be a control group that receives no treatment. This trial is a good opportunity for eligible women to potentially experience less pain during a challenging time.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Speaks Turkish,
- • 37-42 weeks gestation and in vaginal labor,
- • The one with a single fetus and vertex development,
- • Fetal weight between 2000-4000 gr,
- • To have performed with mediolateral episiotomy,
- • Pregnant women admitted to the delivery room,
- Exclusion Criteria:
- • Vacuum applied
- • Forceps delivery
- • Vaginal tear/ Disurge
- • Anal sphincter damage
- • Unusual need for lidocaine during episiotomy repair (more than 10ml)
- • Intact perineum
- • Any postnatal complications in the newborn.
About Uskudar University
Uskudar University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing research and innovation in the fields of psychology, health sciences, and social sciences. As a clinical trial sponsor, Uskudar University leverages its extensive network of experts and cutting-edge facilities to conduct rigorous clinical research aimed at improving patient outcomes and contributing to the global body of scientific knowledge. The university emphasizes ethical research practices and collaboration with healthcare professionals, ensuring that its trials are designed to adhere to the highest standards of safety and efficacy. Through its clinical research initiatives, Uskudar University seeks to foster advancements in medical science and enhance the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Derya Deniz, PhD
Principal Investigator
TC Uskudar University
Ozlem Can Gurkan
Study Director
Marmara University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported